Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon
Thumbnail

16% of heart failure patients delay or skip treatment—many for financial reasons

A majority of patients delaying care came from a low-income household.

Thumbnail

TMVR outcomes suffer when patients have heart failure and diabetes—but benefits remain

Overall, the authors emphasized, TMVR helped heart failure patients with and without diabetes.

Thumbnail

FDA announces recall of 48,000 Boston Scientific pacemakers, CRT-Ps

This is a Class I recall, which means the issue can lead to serious injury or death.

Thumbnail

Missed opportunities: Early heart failure diagnoses often overlooked in outpatient setting

“Making these diagnoses earlier could allow for urgent intervention, preventing the cardiac remodeling and organ dysfunction that accompany delays in treatment,” the study's authors said. 

Thumbnail

Early rhythm control therapy beneficial for AFib patients with suspected heart failure

According to the study's authors, their findings suggest that "all patients with signs or symptoms of heart failure should be considered for rhythm control therapy within a year of being diagnosed with AFib."

Dapagliflozin associated with better long-term outcomes for HFrEF patients

Findings from the study may be helpful in conveying the benefits of dapagliflozin treatment to patients with HFrEF, the authors said. 

Thumbnail

Digital solution for heart failure gains FDA’s breakthrough device designation

The digital therapeutic helps patients follow recommended treatment guidelines by monitoring their health data, connecting them to healthcare providers and personalizing their treatment when necessary.

Thumbnail

Hearts from donors with a history of drug use are safe for transplant

"We thought that illicit drugs like cocaine or methamphetamine, which can lead to heart attacks, would prove to be dangerous,” one researcher said. "However, we were wrong."

Displaying 345 - 352 of 1270

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.